Breaking News Instant updates and real-time market news.

KORS

Michael Kors

$45.41

8.1817 (21.98%)

, RL

Ralph Lauren

$86.41

8.26 (10.57%)

12:20
08/08/17
08/08
12:20
08/08/17
12:20

On The Fly: Top stock stories at midday

Stocks opened in negative territory but the averages saw their lows shortly after the open, making it back across the flat line by the middle of the morning. Each of the averages is now in positive territory as the market tries to extend its rally. Oil prices, which were higher earlier in the day, are now little changed as investors prepare for the API inventory data due out after the close. ECONOMIC EVENTS: In the U.S., the JOLTS report showed job openings surged 461,000 to a record high level of 6.163M in June. In Asia, China exports rose 7.2% and imports grew 11% in July, both of which missed expectations. In Europe, Germany's June trade figures also came in light, with exports falling 2.8% and imports sliding 4.5%, versus expectations for both to risen fractionally. COMPANY NEWS: Two higher end apparel makers - Michael Kors (KORS) and Ralph Lauren (RL) - were among the leading stocks on the S&P 500 after both reported better than expected quarterly sales and profits. Michael Kors, which also gave a better than expected outlook for the fiscal year, jumped 22% on the back of its quarterly report, while Ralph Lauren shares rose 11%. MAJOR MOVERS: Among the other gainers following their earnings reports were Jacobs Engineering (JEC), LendingClub (LC) and Valeant (VRX). Among the noteworthy losers was Depomed (DEPO), which fell over 25% after the company reported weaker than expected second quarter results and lowered its guidance. Reacting to the announcement, Janney Capital and Morgan Stanley downgraded the stock to Neutral and Underweight, respectively. Also lower following their earnings reports were Dean Foods (DF), Avis Budget (CAR) and Wayfair (W). INDEXES: Near midday, the Dow was up 48.01, or 0.22%, to 22,166.43, the Nasdaq was up 36.57, or 0.57%, to 6,420.35, and the S&P 500 was up 8.65, or 0.35%, to 2,489.56.

KORS

Michael Kors

$45.41

8.1817 (21.98%)

RL

Ralph Lauren

$86.41

8.26 (10.57%)

JEC

Jacobs Engineering

$54.60

2.29 (4.38%)

LC

LendingClub

$6.09

0.625 (11.45%)

VRX

Valeant

$16.68

1.31 (8.52%)

DEPO

Depomed

$9.23

-0.24 (-2.53%)

DF

Dean Foods

$12.21

-2.765 (-18.47%)

CAR

Avis Budget

$33.39

1.18 (3.66%)

W

Wayfair

$73.92

-6.655 (-8.26%)

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 09

    Aug

  • 09

    Aug

  • 10

    Aug

  • 10

    Aug

  • 10

    Aug

  • 24

    Aug

KORS Michael Kors
$45.41

8.1817 (21.98%)

07/10/17
MKMP
07/10/17
INITIATION
Target $26
MKMP
Sell
Michael Kors initiated with a Sell at MKM Partners
MKM Partners initiated Michael Kors with a Sell and a $26 price target.
06/01/17
ADAM
06/01/17
NO CHANGE
Target $33
ADAM
Hold
Michael Kors guidance underscores broader challenges ahead, says Canaccord
Canaccord analyst Camilo Lyon noted Michael Kors beat Q4 estimates but said its weaker guidance underscores the broader challenges ahead for the company. Lyon said the company is finally taking aggressive course-correcting action to enhance the brand's position along with cost-savings. The analyst said the macro challenges in the U.S. and Europe remain and there is significant execution risk at hand. Lyon maintained his Hold rating and lowered his price target to $33 from $38 on Michael Kors shares.
06/01/17
UBSW
06/01/17
NO CHANGE
Target $55
UBSW
Buy
Michael Kors store closures positive for Coach, says UBS
UBS analyst Michael Binetti noted Michael Kors (KORS) announced plans to start closing stores and it is assumed they will be skewed to North America. The analyst believes Michael Kors has been the number one competitive pressure for Coach (COH) over the past five years so its decision to close stores now relieves the company of its number one headwind. He now believes Coach is well positioned as a market share gainer. Binetti reiterated his Buy rating and $55 price target on Coach shares.
07/31/17
07/31/17
DOWNGRADE
Target $45

Hold
Coach downgraded to Hold from Buy at Jefferies
Jefferies analyst Randal Konik downgraded Coach (COH) to Hold citing valuation. The company's recovery is playing out, "but everyone knows it," Konik tells investors in a research note. The analyst lowered his price target for Coach shares to $45 from $53 and recommends buying shares of Michael Kors (KORS), where he feels the valuation and expectations are lower.
RL Ralph Lauren
$86.41

8.26 (10.57%)

05/25/17
TIGR
05/25/17
INITIATION
TIGR
Neutral
Ralph Lauren initiated with a Neutral at Tigress Financial
Tigress analyst Ivan Feinseth initiated Ralph Lauren with a Neutral saying business performance continues to deteriorate at a rapid pace due to changes in consumer preference and retail industry headwinds.
04/20/17
OTRG
04/20/17
DOWNGRADE
OTRG
Negative
Ralph Lauren downgraded to Negative from Mixed at OTR Global
OTR Global downgraded Ralph Lauren to Negative saying checks indicate US outlets were hurt by a downturn in traffic and late winter storms in Q4 and orders for July-September are flat to down year-over-year among woman buyers.
07/17/17
BUCK
07/17/17
INITIATION
Target $68
BUCK
Neutral
Ralph Lauren assumed with a Neutral at Buckingham
Buckingham analyst Eric Tracy assumed coverage of Ralph Lauren with a Neutral rating and $68 price target.
07/18/17
NEED
07/18/17
INITIATION
NEED
Hold
Ralph Lauren initiated with a Hold at Needham
JEC Jacobs Engineering
$54.60

2.29 (4.38%)

08/03/17
SBSH
08/03/17
DOWNGRADE
Target $62
SBSH
Neutral
Jacobs Engineering downgraded to Neutral from Buy at Citi
Citi analyst Andrew Kaplowitz downgraded Jacobs Engineering to Neutral saying the price paid for CH2M is expensive and that the company's balance sheet is no longer a catalyst. The analyst lowered his price target for the shares to $62 from $66.
12/13/16
JEFF
12/13/16
DOWNGRADE
Target $64
JEFF
Hold
Jacobs Engineering downgraded to Hold from Buy at Jefferies
Jefferies analyst Martin Englert downgraded Jacobs Engineering to Hold citing a more balanced risk/reward following the recent rally in shares. The analyst upped his price target to $64 from $54.
06/02/17
ARGS
06/02/17
NO CHANGE
ARGS
Jacobs Engineering weakness creates buying opportunity, says Argus
Argus analyst John Eade says that Jacobs is "showing signs of a turnaround" after the stock declined 3% over the last three months. He notes that the company reported better than expected Q2 results, and he thinks that it can benefit from infrastructure enhancement plans in the U.S., Canada, and Australia. The analyst recommends buying the shares.
02/22/17
ARGS
02/22/17
NO CHANGE
ARGS
Jacobs Engineering recent weakness creates buying opportunity, says Argus
Argus analyst John Eade says that Jacobs' stock has underperformed for the past two months, falling 2%. He says that the company's turnaround is continuing to progress, while it should benefit from the increased focus on infrastructure. The analyst keeps a Buy rating on the shares.
LC LendingClub
$6.09

0.625 (11.45%)

08/03/17
OPCO
08/03/17
UPGRADE
OPCO
Outperform
LendingClub upgraded to Outperform from Perform at Oppenheimer
08/03/17
08/03/17
UPGRADE
Target $7

Outperform
LendingClub upgraded to Outperform at Oppenheimer
As previously reported, Oppenheimer analyst Jed Kelly upgraded LendingClub to Outperform from Perform, with a $7 price target, as he believes it is creating a sticker investor base through a higher Bank/Retail mix, while utilizing its strong balance sheet to develop a potentially large securitization channel.
05/01/17
05/01/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Capital One (COF) upgraded to Buy from Hold at Deutsche Bank with analyst David Ho saying loss curves for the bulk of the company's recent card vintage growth should continue to improve. The analyst keeps a $98 price target for the shares. 2. First Solar (FSLR) upgraded to Neutral from Underperform at Credit Suisse with analyst Andrew Hughes citing the potential that Suniva's Section 201 trade complaint succeeds combined with a 23% short interest in the name. 3. Dunkin' Brands (DNKN) upgraded to Outperform from Sector Perform at RBC Capital with analyst David Palmer saying he thinks that initiatives being taken by the company, including "renewed focus on coffee and profitability," will "improve franchisee profitability, core customer satisfaction," and revenue growth. 4. Waters (WAT) upgraded to Buy from Neutral at Janney Capital with analyst Paul Knight saying he expects the company to be a will be a key beneficiary as the Life Science Industry transitions to faster growth in 2017. Knight raised his fair value estimate on Waters shares to $200 from $185. 5. LendingClub (LC) upgraded to Positive from Neutral at Susquehanna with analyst James Friedmansaying his analysis suggests sufficient first quarter momentum to create an upward bias in 2017 and 2018 consensus forecasts. He believes the upside is not contemplated in the current valuation or the high short interest. Friedman raised his price target on LendingClub shares to $9 from $6. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/01/17
SUSQ
05/01/17
UPGRADE
Target $9
SUSQ
Positive
LendingClub upgraded to Positive at Susquehanna
As reported previously, Susquehanna analyst James Friedman upgraded LendingClub to Positive from Neutral as his analysis suggests sufficient Q1 momentum to create an upward bias in 2017 and 2018 consensus forecasts. He believes the upside is not contemplated in the current valuation or the high short interest. Friedman raised his price target on LendingClub shares to $9 from $6.
VRX Valeant
$16.68

1.31 (8.52%)

07/17/17
WELS
07/17/17
NO CHANGE
WELS
Underperform
Wells says Valeant selling Obagi for less than half of price paid in 2013
After Valeant announced it has agreed to sell its Obagi Medical Products business for $190M in cash, Wells Fargo analyst David Maris noted that this sale price is less than half of the $437M that the company paid to acquire Obagi in April 2013. While Valeant continues to make progress toward its asset sales and debt reduction targets, Maris does not believe that its recent divestitures have had a significant deleveraging impact. He keeps an Underperform rating on Valeant shares.
07/28/17
WELS
07/28/17
NO CHANGE
Target $9
WELS
Underperform
Insurers are dropping Valeant's top products, says Wells Fargo
United Healthcare's (UNH) formulary is no longer covering Valeant Pharmaceuticals' (VRX) number three branded drug Solodyn and will also now exclude Retin-A brand, its number four branded drug, Wells Fargo analyst David Maris tells investors in a research note. The analyst estimates the two drugs represented approximately $214M of Valeant's sales in 2016. Maris also points out that Glumetza, Valeant's number eight branded drug, and Relistor were removed in July from CVS/Caremark's (CVS) formulary. These two drugs had approximately $119M in 2016 revenues. Maris notes his counterpart Peter Costa estimates that United Healthcare covers approximately 17% of the U.S. and CVS covers approximately 33%. Express Scripts (ESRX) is releasing its 2018 national formulary next week, Costa adds. Maris keeps an Underperform rating on shares of Valeant with a $9 price target. The stock in premarket trading is down 33c, or 2%, to $16.80.
07/27/17
WELS
07/27/17
NO CHANGE
WELS
Underperform
Doctors not optimistic about Valeant's Siliq, says Wells Fargo
Wells Fargo analyst David Maris says the dozens of doctors he spoke to about Valeant Pharmaceuticals' Siliq are not optimistic. Over 50% of the physicians surveyed said they would use Siliq only as a fourth line therapy or later, Maris tells investors in a research note after Valeant announced the launch of the moderate-to-severe plaque psoriasis treatment. The analyst disagrees with Valeant management's claims that Siliq has "very large peak sales potential." The injection carries a warning about risk of suicide and Valeant will be competing against a large number of peers with greater resources, Maris argues. The analyst has an Underperform rating on Valeant shares, which are down 18c to $17.59 in midday trading.
08/04/17
WELS
08/04/17
NO CHANGE
WELS
Underperform
Valeant's Isuprel to face generic from Nexus, says Wells Fargo
Wells Fargo analyst David Maris noted that the FDA is reporting, and Nexus Pharmaceuticals has confirmed to him, that the company received approval for a generic version of Valeant's Isuprel. Nexus expects to "command the lion's share" of the U.S. market for the drug, as its version is made in the U.S. and has longer stability than Valeant's version, Maris tells investors. The analyst, who notes that Valeant previously indicated it anticipated that Isuprel would lose exclusivity in Q4, keeps an Underperform rating on the stock.
DEPO Depomed
$9.23

-0.24 (-2.53%)

08/08/17
08/08/17
DOWNGRADE
Target $8

Neutral
Depomed downgraded to Neutral after another guidance cut at Janney Capital
As previously reported, Janney Capital analyst Ken Trbovich downgraded Depomed to Neutral from Buy, saying he reads the company's surprising lowering of its full-year guidance for revenues and raising of its expense guidance as an admission that the challenges facing its business are far greater to overcome than just fixing its sales force alignment. Trbovich, who noted that this was the fifth time in the past six quarters that Depomed has lowered the upper end of its revenue view, cut his fair value estimate on the stock to $8 from $18.
08/08/17
MSCO
08/08/17
DOWNGRADE
MSCO
Underweight
Depomed downgraded to Underweight from Equal Weight at Morgan Stanley
08/08/17
08/08/17
DOWNGRADE
Target $5

Underweight
Depomed downgraded to Underweight at Morgan Stanley
As previously reported, Morgan Stanley downgraded Depomed to Underweight and slashed its price target to $5 from $12. Analyst David Risinger believes pressures on Nucynta, an opiod for pain, will continue to persist as prescriptions decline.
08/08/17
JANY
08/08/17
DOWNGRADE
JANY
Neutral
Depomed downgraded to Neutral from Buy at Janney Capital
DF Dean Foods
$12.21

-2.765 (-18.47%)

08/08/17
JPMS
08/08/17
DOWNGRADE
Target $12
JPMS
Neutral
Dean Foods downgraded to Neutral with $12 target at JPMorgan
JPMorgan analyst Ken Goldman downgraded Dean Foods to Neutral from Overweight and cut his price target for the shares to $12 from $22 following the company's weaker than expected Q2 results. The analyst attributes the results to competitive and macro pressures. Stephens also downgraded the shares today post-earnings.
08/08/17
JPMS
08/08/17
DOWNGRADE
JPMS
Neutral
Dean Foods downgraded to Neutral from Overweight at JPMorgan
08/08/17
SPHN
08/08/17
DOWNGRADE
SPHN
Equal Weight
Dean Foods downgraded to Equal Weight from Overweight at Stephens
08/08/17
08/08/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Dean Foods (DF) was downgraded to Neutral from Overweight at JPMorgan and to Equal Weight from Overweight at Stephens. 2. Armstrong Flooring (AFI) downgraded to Hold from Buy at Gabelli. 3. Plains All American (PAA) was downgraded to Neutral from Outperform at Baird and to Sector Perform at Scotia Howard Weil. 4. Beazer Homes (BZH) downgraded to Neutral from Outperform at Wedbush with analyst Jay McCanless citing valuation and lack of near-term catalysts. 5. Noble Corp. (NE) downgraded to Hold from Buy at Societe Generale with analyst Edward Muztafago saying the weak pricing environment will limit near-term improvement in the deepwater market and believes it will be second half 2018, at the earliest, before new project work picks up more materially. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CAR Avis Budget
$33.39

1.18 (3.66%)

08/04/17
08/04/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Square (SQ) initiated with a Neutral at Wedbush. 2. Avis Budget (CAR) was initiated with an Overweight at JPMorgan while Hertz (HTZ) was initiated with a Neutral at the firm. 3. IBM (IBM) initiated with a Neutral at Wedbush. 4. Amtech Systems (ASYS) initiated with a Buy at Roth Capital. 5. Franklin Financial Network (FSB) initiated with a Market Perform at Hovde Group. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/04/17
JPMS
08/04/17
INITIATION
Target $39
JPMS
Overweight
Avis Budget initiated with an Overweight at JPMorgan
JPMorgan analyst Samik Chatterjee started Avis Budget with an Overweight rating and $39 price target. The analyst highlights the company's experienced management team and sees upside from its ownership of Zipcar.
06/26/17
DBAB
06/26/17
NO CHANGE
DBAB
Buy
Avis announcement of Waymo management pact a positive, says Deutsche Bank
Deutsche Bank analyst Chris Woronka said he views news of the multi-year fleet management contract with Alphabet's (GOOG) Waymo as a positive for Avis Budget (CAR) that came as a surprise to most. He sees the deal as an indication that logistics management and access to on-airport real estate are real assets for the rental car companies, adding that he expects news flow on Avis' involvement in autonomous driving to increase as more of these vehicles hit the road. Woronka keeps a Buy rating on Avis shares.
06/27/17
MKMP
06/27/17
NO CHANGE
MKMP
Autonomous vehicle deals positive for car rental companies, says MKM Partners
After Avis (CAR) announced a multi-year deal with on autonomous vehicles with Alphabet's (GOOG, GOOGL) Waymo and news reports stated that Hertz (HTZ) is working with Apple (AAPL) on autonomous vehicles, MKM Partners analyst Christopher Agnew says the news should ease investors' concerns about car rental companies no longer existing in five to ten years. The analyst believes that car rental companies will become "more relevant" following the launch of autonomous vehicles due to their fleet management skills. He keeps Buy ratings on Hertz and Avis.
W Wayfair
$73.92

-6.655 (-8.26%)

07/13/17
BUCK
07/13/17
NO CHANGE
Target $95
BUCK
Buy
Wayfair price target raised to $95 from $72 at Buckingham
Buckingham analyst Kelly Halsor reiterates a Buy rating on Wayfair and raised her price target for the shares to $95 from $72. The analyst believes a higher valuation multiple is justified given the reacceleration of direct revenue growth in Q2 and increased acquisition activity by big box retailers.
06/30/17
PIPR
06/30/17
NO CHANGE
Target $87
PIPR
Overweight
Piper analysis shows Wayfair Direct Retail revenue above guidance
Piper Jaffray analyst Peter Keith says his firm's proprietary analysis of Google search trends indicates Wayfair Direct Retail revenue growth of 46% for Q2 versus guidance of 34%-37% and consensus of 40%. The "strong" Direct Retail revenue growth reacceleration is being driven by increased product offerings, exclusivity of products, strategic investments in logistics and supply chain, and increased customer satisfaction due to positive delivery execution, Keith tells investors in a research note. He raised his Q2 revenue estimate to $1.084B, above the consensus of $1.056B, and reiterates an Overweight rating on Wayfair with an $87 price target.
08/03/17
WOLF
08/03/17
INITIATION
Target $88
WOLF
Outperform
Wayfair initiated with an Outperform at Wolfe Research
After the market close last night, Wolfe Research analyst Adrienne Yih started Wayfair with an Outperform rating and $88 price target, calling it the home goods market's "premiere e-commerce growth play."
08/04/17
OPCO
08/04/17
NO CHANGE
Target $88
OPCO
Outperform
Wayfair price target raised to $88 from $80 at Oppenheimer
Oppenheimer analyst Brian Nagel raised his price target for Wayfair to $88 ahead of the company's Q2 results on August 8. Industry data has remained solid while key internal initiatives at Wayfair continue to take hold, Nagel tells investors in a pre-earnings research note. He's "optimistic" that further indications of elevated sales growth should prove another positive, near-term catalyst for shares. Nagel stays Outperform-rated on Wayfair. The online retailer closed yesterday up $3.50 to $77.33.

TODAY'S FREE FLY STORIES

APTX

Aptinyx

$0.00

(0.00%)

20:45
06/20/18
06/20
20:45
06/20/18
20:45
Syndicate
Aptinyx 6.4M share IPO priced at $16.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

AVRO

AvroBio

$0.00

(0.00%)

20:44
06/20/18
06/20
20:44
06/20/18
20:44
Syndicate
AvroBio 5.25M share IPO priced at $19.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

TV

Televisa

$18.25

0.51 (2.87%)

20:43
06/20/18
06/20
20:43
06/20/18
20:43
Downgrade
Televisa rating change  »

Televisa downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CX

Cemex

$6.33

0.115 (1.85%)

20:42
06/20/18
06/20
20:42
06/20/18
20:42
Upgrade
Cemex rating change  »

Cemex upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PH

Parker-Hannifin

$164.49

0.74 (0.45%)

20:41
06/20/18
06/20
20:41
06/20/18
20:41
Downgrade
Parker-Hannifin rating change  »

Parker-Hannifin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMT

Kennametal

$37.44

1.11 (3.06%)

20:41
06/20/18
06/20
20:41
06/20/18
20:41
Downgrade
Kennametal rating change  »

Kennametal downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYNT

Syntel

$34.07

0.65 (1.94%)

20:40
06/20/18
06/20
20:40
06/20/18
20:40
Downgrade
Syntel rating change  »

Syntel downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

MGTA

Magenta Therapeutics

$0.00

(0.00%)

20:28
06/20/18
06/20
20:28
06/20/18
20:28
Syndicate
Magenta Therapeutics 6.667M share IPO priced at $15.00 »

The deal priced in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

XERS

Xeris Pharmaceuticals

$0.00

(0.00%)

20:26
06/20/18
06/20
20:26
06/20/18
20:26
Syndicate
Xeris Pharmaceuticals 5.7M share IPO priced at $15.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

KR

Kroger

$26.21

0.21 (0.81%)

, DRI

Darden

$93.27

-1.34 (-1.42%)

20:25
06/20/18
06/20
20:25
06/20/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

KR

Kroger

$26.21

0.21 (0.81%)

DRI

Darden

$93.27

-1.34 (-1.42%)

CMC

Commercial Metals

$23.67

0.44 (1.89%)

PDCO

Patterson Companies

$22.54

0.07 (0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

  • 21

    Jun

  • 21

    Jun

  • 28

    Jun

  • 10

    Jul

IIIV

i3 Verticals

$0.00

(0.00%)

20:24
06/20/18
06/20
20:24
06/20/18
20:24
Syndicate
i3 Verticals 6.65M share IPO priced at $13.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

KZR

Kezar Life Sciences

$0.00

(0.00%)

20:23
06/20/18
06/20
20:23
06/20/18
20:23
Syndicate
Kezar Life Sciences 5M share IPO priced at $15.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

LPL

LG Display

$8.91

-0.015 (-0.17%)

20:08
06/20/18
06/20
20:08
06/20/18
20:08
Periodicals
LG Display discussing early retirement options for workers, Bloomberg reports »

LG Display is considering…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGO

Eldorado Gold

$1.13

-0.02 (-1.75%)

20:05
06/20/18
06/20
20:05
06/20/18
20:05
Hot Stocks
Eldorado Gold provides update on Lamaque exploration and development »

Eldorado Gold is pleased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, RSX

Market Vectors Russia ETF

$20.52

0.22 (1.08%)

19:43
06/20/18
06/20
19:43
06/20/18
19:43
Periodicals
Trump planning to meet with Russia's Putin in Europe next month, Bloomberg says »

Donald Trump and…

SPX

S&P 500

$0.00

(0.00%)

RSX

Market Vectors Russia ETF

$20.52

0.22 (1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEO

CNOOC

$163.48

2.345 (1.46%)

19:29
06/20/18
06/20
19:29
06/20/18
19:29
Periodicals
CNOOC to proceed with expansion in Canada's oil sands, Reuters reports »

CNOOC's Nexen Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TM

Toyota

$134.34

-1.815 (-1.33%)

19:14
06/20/18
06/20
19:14
06/20/18
19:14
Periodicals
Toyota to reduce marketing costs to fund new research, Reuters reports »

Toyota Motors has started…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$202.08

4.62 (2.34%)

, GOOG

Alphabet

$1,169.38

1.52 (0.13%)

19:06
06/20/18
06/20
19:06
06/20/18
19:06
Periodicals
FTC chair wants to explore market power of big internet firms, Reuters says »

New U.S. Federal Trade…

FB

Facebook

$202.08

4.62 (2.34%)

GOOG

Alphabet

$1,169.38

1.52 (0.13%)

GOOGL

Alphabet Class A

$1,183.83

5.54 (0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

RYAAY

Ryanair

$117.11

3.54 (3.12%)

19:01
06/20/18
06/20
19:01
06/20/18
19:01
Periodicals
IAG, Ryanair preparing EU legal challenge over air traffic strikes, FT reports »

IAG and Ryanair are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BNED

Barnes & Noble Education

$6.78

0.3 (4.63%)

, MU

Micron

$58.97

-0.26 (-0.44%)

19:00
06/20/18
06/20
19:00
06/20/18
19:00
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Barnes…

BNED

Barnes & Noble Education

$6.78

0.3 (4.63%)

MU

Micron

$58.97

-0.26 (-0.44%)

SCS

Steelcase

$15.55

0.2 (1.30%)

LITE

Lumentum

$56.45

0.8 (1.44%)

HPQ

HP Inc.

$23.31

-0.215 (-0.91%)

THO

Thor Industries

$104.81

6.5 (6.61%)

GLW

Corning

$28.40

0.015 (0.05%)

AOBC

American Outdoor Brands

$13.22

0.13 (0.99%)

LMNR

Limoneira

$26.65

0.63 (2.42%)

VERI

Veritone

$21.52

-0.64 (-2.89%)

TRUP

Trupanion

$41.07

0.8 (1.99%)

ARRS

Arris

$25.51

0.015 (0.06%)

WIX

Wix.com

$107.70

1.15 (1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 20

    Jun

  • 20

    Jun

  • 21

    Jun

  • 21

    Jun

  • 22

    Jun

  • 09

    Jul

  • 10

    Jul

  • 11

    Jul

  • 12

    Jul

  • 21

    Jun

  • 21

    Jun

  • 21

    Jun

DIS

Disney

$107.28

1.08 (1.02%)

18:55
06/20/18
06/20
18:55
06/20/18
18:55
Periodicals
Disney puts future 'Star Wars' spinoffs on hold, Collider reports »

Disney's Lucasfilm…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

SPY

SPDR S&P 500 ETF Trust

$276.00

0.52 (0.19%)

, SPX

S&P 500

$0.00

(0.00%)

18:54
06/20/18
06/20
18:54
06/20/18
18:54
Periodicals
Trump sees U.S. quarterly GDP going much higher, Bloomberg reports »

Says the head of U.S.…

SPY

SPDR S&P 500 ETF Trust

$276.00

0.52 (0.19%)

SPX

S&P 500

$0.00

(0.00%)

X

U.S. Steel

$35.72

0.56 (1.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,169.38

1.52 (0.13%)

, GOOGL

Alphabet Class A

$1,183.83

5.54 (0.47%)

18:51
06/20/18
06/20
18:51
06/20/18
18:51
Hot Stocks
Senators Cotton, Rubio urge Google to reconsider work with Huawei »

Senator Tom Cotton along…

GOOG

Alphabet

$1,169.38

1.52 (0.13%)

GOOGL

Alphabet Class A

$1,183.83

5.54 (0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

YTRA

Yatra

$7.14

-0.04 (-0.56%)

18:48
06/20/18
06/20
18:48
06/20/18
18:48
Syndicate
Yatra files to sell 8.5M ordinary shares »

Citigroup and Jefferies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOA

North American Energy

$5.70

0.05 (0.88%)

18:04
06/20/18
06/20
18:04
06/20/18
18:04
Hot Stocks
North American Construction Group awarded $160M contract from oil sands customer »

North American…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.